# Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

> **NCT00116090** · — · COMPLETED · sponsor: **National Eye Institute (NEI)** · enrollment: 6300 (—)

## Conditions studied

- Uveitis
- Cancer
- Infection
- Mortality
- Immunosuppression

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00116090
- **Lead sponsor:** National Eye Institute (NEI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06-16
- **Primary completion:** —
- **Final completion:** 2008-04-21
- **Target enrollment:** 6300 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00116090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00116090, "Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00116090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*